抗生素PPT课件（英文精品） Review of Antibiotics(84p)PPT.ppt

Review of AntibioticsPart 1;Penicillin - Spectrum;Penicillin - Mechanism of  Action;Penicillin and Pneumococcus;Penicillin - Neisseria;Penicillin - Clinical Uses;Ampicillin - Spectrum;Ampicillin and Enteroccocus;Ampicillin and Haemophillus;Ampicillin and Salmonella;Ampicillin - Dosing;Ampicillin - Clinical Uses;S. aureus - beta lactamase;;Beta-lactamase-Resistant Penicillins;Nafcillin/Oxacillin - Spectrum;Nafcillin/Oxacillin - Pearls;Nafcillin/Oxacillin - Clinical Uses;Anti-pseudomonal Penicillins;Piperacillin - Spectrum;Piperacillin dosing;Beta-lactam/Beta-lactamase Inhibitor Combinations;Unasyn - Spectrum;Unasyn - Dosing;Unasyn - Clinical Uses;Zosyn - Spectrum;Zosyn - Dosing;Zosyn - Clinical Uses;Cephalosporins;First Generation Cephalosporins;Ancef - Spectrum;Ancef - Clinical Uses;Second Generation Cephalosporins;Cefuroxime/Cefotetan - Spectrum;1st vs 2nd Generation;Cefuroxime - Clinical Uses;Cefotetan/Cefoxitin - Clinical Uses;Third Generation Cephalosporins;Claforan/Rocephin - Spectrum;Fortaz - Spectrum;Claforan/Rocephin -Clinical Uses;Fortaz - Clinical Uses;Fourth Generation Cephalosporin;;*B?cher K et al. J Antimicrob Chemother. 1992;30:365-375.;GRAM-NEGATIVE IN VITRO*ACTIVITY OF CEFEPIME;*In vitro activity does not necessarily correlate with clinical results. ?Cefepime has been shown to be active against susceptible strains of these pathogens in clinical infections.;Maxipime - Clinical Uses;Cephalosporins;Carbipenems;Primaxin/Merem/Dorimax -  Antibacterial Spectrum;Imipenem - Primaxin  Toxicity;Merem - Toxicity;Ertapenem spectrum;Vancomycin;Vancomycin;Vancomycin - Toxicity;Vancomycin - Dosing;Vancomycin - Dosing;Vancomycin - Dosing Random Levels;Trimethoprim/Sulfamethoxazole;Trimethoprim/Sulfamethoxazole;Uses of Trimethoprim/Sulfamethoxazole;Rifampin;Rifampin - Toxicity;Rifampin - Drug-Drug Interactions;Synercid - quinupristin;Synercid - dalfopristin;Synercid;Synercid - Antibacterial Spectrum;Synercid - Administration;Synercid - Drug inte